Julie Yoo
Showing 1–11 of 11 transcripts.
- Milken Institute45 min
Can Globalization Be Great Again? Doing Business in a Changing World | Asia Summit 2025
Julie Yoo, Namsun Kim, Kawal Preet, Aseem Puri, Dyah Roro Esti Widya Putri
The "State of Globalization" summit convened Indonesian government officials and global leaders from Unilever, FedEx, and Naver to analyze the shift from a unipolar, integrated world to a multipolar landscape defined by fragmentation and protectionism. Panelists detailed strategic adaptations, including Indonesia's aggressive ratification of trade agreements like CEPA and SIPA to leverage its 68% export reliance on free trade partners, alongside corporate pivots toward emerging markets in Africa and Asia that prioritize agility and AI-driven logistics. The event concluded with a consensus that while the era of frictionless trade is over, businesses must act as pioneers by leveraging sustainability and digital tools to navigate a permanent state of geopolitical volatility.
- a16z22 min
AI: The Ultimate Healthcare Hire
Facing a severe clinical shortage driven by an aging workforce and high burnout rates, the healthcare sector is pivoting toward an AI-powered "super staffing" model that unbundles administrative tasks from physician duties to unlock immediate capacity. This strategy leverages ambient scribes and autonomous agents to shift spending from traditional IT budgets to labor costs, allowing hospitals to fill open headcount gaps without waiting for new clinical training pipelines. While adoption is accelerating due to the industry's ability to leapfrog legacy infrastructure, successful implementation must navigate persistent regulatory uncertainties and integration challenges posed by decades-old electronic health record systems.
- a16z27 min
The Future of Health Insurance in a Work Remote World
Chris Ellis, Adam Stevenson, Julie Yoo, Jay Rughani
Thatch is deploying fintech solutions to operationalize Individual Coverage Health Reimbursement Arrangements, shifting employer-sponsored healthcare from a static, tied model to a portable system that mirrors the 401(k) evolution. By enabling tax-free funding for workers to purchase individual plans, the platform addresses labor market friction where fear of coverage loss inhibits mobility while driving triple-digit carrier growth as traditional sectors stagnate. Early adoption data shows 40% of users growing monthly balances, signaling a trajectory toward a competitive market where free funds can be reallocated to preventative care and niche insurance providers.
- a16z35 min
Implementation, Data, Impact of Healthcare AI with Julie and Vijay
Industry leaders project that AI agents will reduce healthcare costs by up to 50% through labor arbitrage and prevention-focused value-based care, while simultaneously compressing training times from months to days. Despite these economic advantages, widespread adoption faces significant hurdles including regulatory ambiguity over AI credentialing, the inelastic nature of healthcare demand, and the critical need to shift from retrospective records to prospective data generation. To overcome these barriers, organizations are reclassifying technology as labor, utilizing AI as a recruitment tool to reduce clinician burnout, and transitioning toward hybrid models where human oversight manages complex exceptions while automated systems handle routine phenotyping and triage.
- a16z38 min
Grand Challenges in Healthcare AI with Vijay Pande and Julie Yoo
Amidst a healthcare labor crisis and provider burnout, AI adoption is accelerating through administrative efficiencies in revenue cycle management and the digitization of complex payer-provider contracts. Strategic startups are targeting near-term opportunities by embedding natural language interfaces into existing Electronic Health Records, automating prior authorization, and restructuring clinical trials through real-world data analysis. While full-stack AI clinicians remain a distant goal, the immediate landscape prioritizes behavioral change strategies, unbundled care roles, and value-based care alignment to optimize patient outcomes and reduce systemic waste.
- a16z24 min
Big Ideas in 2024: Democratizing “Miracle Drugs” with Julie Yoo
Andreessen Horowitz partners project that democratizing miracle drugs like GLP-1s and cell therapies will define 2024, driven by a massive eligible U.S. population and the urgent need to prevent healthcare system insolvency. While these programmable medicines offer curative potential, their current exorbitant costs and complex logistics create severe friction in financing, manufacturing, and clinical operations. The industry is responding with 2024-focused innovations in industrialized biomanufacturing, fintech risk-spreading instruments, and real-world data infrastructure, all while awaiting necessary regulatory adaptations from the FDA and CMS.
- a16z51 min
When Two Giants Intersect: Healthcare Meets Fintech
Amidst a US healthcare crisis defined by $4.3 trillion in annual spending and systemic inefficiencies, new regulatory mandates for price transparency are catalyzing a wave of fintech innovation aimed at realigning incentives across providers, payers, and consumers. Startups like Juniper and Thatch are leveraging value-based payment models and embedded financial infrastructure to automate revenue cycles and optimize benefit utilization, while tech-native carriers address critical gaps in preventative care and high-cost drug coverage. This rapidly evolving sector demands hybrid founding teams capable of navigating complex state regulations to bridge the operational divide between agile startups and massive legacy incumbents.
- a16z1h 12m
2023 Big Ideas in Technology (Part 2)
Anish Acharya, Angela Strange, Michelle Volz, Ryan McEntush, Vijay Pande, Julie Yoo
Anish Charya and Angela Strange outline transformative fintech strategies where GPT-driven credit counseling scales labor efficiency while software-enabled compliance converts regulatory burdens into strategic competitive moats. Parallel discussions led by Michelle Foles and Ryan McIntosh highlight how Small Modular Reactors and space supply chain overhauls will redefine energy production and industrial supremacy through advanced manufacturing and resource extraction. These innovation themes converge with healthcare predictions from Vijay Pandey and Julie Yu, who forecast the rise of consumer health tech and value-based care stacks to replace legacy fee-for-service models with outcome-focused infrastructure.
- a16z8 min
The New Tech Stack for Virtual-First Care
The digital health sector is undergoing a transformative shift from isolated startup solutions to full-stack virtual clinics that leverage AI and modern technology to lower costs and improve care scale. While early growth was marked by redundant development of proprietary technology stacks, the market is now reaching a tipping point where demand supports dedicated infrastructure providers to abstract common clinical, administrative, and operational layers. Industry consolidation is anticipated as successful players evolve into risk-bearing, multi-stakeholder platforms that integrate digital and physical services to create network effects and eventually displace legacy fee-for-service models.
- a16z15 min
Healthcare: The Great Unlock
Accelerated by the pandemic, the healthcare sector is compressing a decade of transformation into two to three years through a fundamental shift from local, fee-for-service models to national, digital-first, value-based care. This dislocation is driven by labor reversals, insurance coverage changes, and regulatory mandates that favor remote care, forcing legacy providers to cede ground to startups owning the end-to-end patient journey. Consequently, a once-in-a-generation opportunity has emerged for startups to replace fragmented infrastructure with an automated, interoperable operating system that utilizes AI for intelligent supply-demand matching and dynamic insurance products.
- a16z18 min
Software Eats Care Delivery
A16Z BioFund partners identify the healthcare sector as a transformative growth opportunity comparable to the internet in 1999, driven by urgent needs for automation, data interoperability, and consumer-centric service models. The firm prioritizes investments in startups that streamline high-volume administrative tasks, unbundle acute care facilities, and leverage AI to enhance patient outcomes rather than replace clinical judgment. A16Z evaluates these opportunities by targeting companies with clear return on investment, recurring revenue streams, and distribution advantages that can overcome industry-wide inefficiencies and rising patient financial burdens.